FindTrial
Sign In

Prevalence of frailty in critically ill cancer patients and its impact on clinical outcomes and quality of life

Prevalence of frailty in critically ill cancer patients and its impact on outcome. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066841
Enrollment
250
Registered
2024-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D498- Neoplasm of unspecified behavior of other specified sites

Interventions

Intervention1: NIL: NIL

Sponsors

DrSuresh Kumar S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: all critically ill adult patients aged above 18 years with cancer

Exclusion criteria

Exclusion criteria: patients on end of life care

Design outcomes

Primary

MeasureTime frame
Prevalence of frailty in critically ill cancer patientsTimepoint: baseline—

Secondary

MeasureTime frame
1. ICU LOS 2. Requirement for assisted breathing 3. Requirement for vasopressors 4. ICU readmission 5. Hospital LOS 6. Time to mobilization 7. ICU mortality 8. Hospital mortality 9. Post hospital discharge Quality of life Timepoint: all parameters except post hospital discahrge Quality of life assessed during ICU and hospital stay. post hospital discahrge Quality of life assessed at 90 days after discharge from hospital—

Countries

India

Contacts

Public ContactDr SURESH KUMAR S

Apollo Proton Cancer Centre

surkum85@gmail.com9999942084

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026